-transparent.png){kind=logo}
We undertook this study to determine whether predictors of positive placebo response in chronic schizophrenic outpatients could be identified. Twelve placebo responders and 33 placebo nonresponders who participated in a parallel-group, double-blind, 12-week clinical drug trial were compared. No significant differences between the groups were found with regard to 16 anamnestic and symptom variables. To investigate further which variables at baseline predicted positive placebo response, a stepwise linear regression model was created. Of the seven variables entered into the model, only high scores in the positive domain of the Positive and Negative Syndrome Scale (delusions, unusual thought content, grandiosity, and suspiciousness/persecution) at baseline predicted significantly positive placebo response (p = .0047). Because the onset of placebo response was gradual, the authors hypothesize that placebo response in chronic schizophrenia consists mainly of two ingredients: nonspecific psychotherapeutic effect caused by the several assessments carried out during the study, and regression toward the mean.
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
January 1960,
A.M.A. archives of general psychiatry,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
November 1981,
The Journal of nervous and mental disease,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
January 1989,
Comprehensive psychiatry,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
May 1966,
Archives of general psychiatry,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
March 1986,
The Psychiatric clinics of North America,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
March 1975,
Diseases of the nervous system,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
October 1985,
Journal of consulting and clinical psychology,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
December 2005,
Revue d'epidemiologie et de sante publique,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
July 1971,
Hospital & community psychiatry,
T Taiminen, and
E Syvalahti, and
S Saarijarvi, and
H Niemi, and
H Lehto, and
V Ahola, and
R K Salokangas
September 1972,
Current therapeutic research, clinical and experimental,
